JF

Mr Jack Fisher

Connect with Jack

Email: J.G.Fisher@soton.ac.uk

ORCID

Publications

5 publications

Page 1 of 1

Targeting KIR as a novel approach to improve CAR-NK cell function

Lara V. Graham, Jack G. Fisher, Salim I. Khakoo & Matthew D. Blunt, 2023, Journal of Translational Genetics and Genomics, 7(4), 230-235

DOI: 10.20517/jtgg.2023.25

Type: article

XPO1 inhibition sensitises CLL cells to NK cell mediated cytotoxicity and overcomes HLA-E expression

Jack G. Fisher, Amber D.P. Doyle, Lara V. Graham, Shreyanshi Sonar, Ben Sale, Isla Henderson, Luis Del Rio, Peter W.M. Johnson, Yosef Landesman, Mark S. Cragg, Francesco Forconi, Christopher J. Walker, Salim I. Khakoo & Matthew D. Blunt, 2023, Leukemia, 37(10), 2036-2049

DOI: 10.1038/s41375-023-01984-z

Type: article

Disruption of the NKG2A:HLA-E immune checkpoint axis to enhance NK cell activation against Cancer

Jack G. Fisher, Amber D. P. Doyle, Lara V. Graham, Salim I. Khakoo & Matthew D. Blunt, 2022, Vaccines, 10(12)

DOI: 10.3390/vaccines10121993

Type: article

KIR2DS2 expression identifies NK cells with enhanced anticancer activity

Matthew Blunt, Mark Cragg, Amber Doyle, Jack, Graham Fisher, Salim Khakoo, Francesco Forconi, Peter Johnson, Marta Ewa Polak, Lara, Victoria Graham, Andres Vallejo Pulido, Rebecca Fulton & Matthew Carter, 2022, The Journal of Immunology, 209 (2)(2), 379-390

DOI: 10.4049/jimmunol.2101139

Type: article

Selinexor enhances NK cell activation against malignant B cells via downregulation of HLA-E

Jack, Graham Fisher, Salim Khakoo, Mark Cragg, Francesco Forconi, Peter Johnson, Amber Doyle, christopher Walker, yosef landesman & Matthew Blunt, 2021, Frontiers in Oncology

DOI: 10.3389/fonc.2021.785635

Type: article

How to edit profile